Fatty Acid Metabolism-Related lncRNAs are Potential Biomarkers for Predicting Prognoses and Immune Responses in Patients with Skin Cutaneous Melanoma

References

• Coricovac D, Dehelean C, Moaca E-A, et al. Cutaneous Melanoma-A Long Road from Experimental Models to Clinical Outcome: a Review. Int J Mol Sci. 2018;19(6):1566. doi:10.3390/ijms19061566
   PubMed Web of Science ®Google Scholar
• Holmes D. The cancer that rises with the sun. Nature. 2014;515(7527):S110–1. doi:10.1038/515S110a
   PubMed Web of Science ®Google Scholar
• Miller R, Walker S, Shui I, et al. Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review. Melanoma Manag. 2020;7(1):Mmt39. doi:10.2217/mmt-2019-0022
   PubMed Web of Science ®Google Scholar
• Conic RZ, Cabrera CI, Khorana AA, et al. Determination of the impact of melanoma surgical timing on survival using the National Cancer Database. J Am Acad Dermatol. 2018;78(1):40–46.e7. doi:10.1016/j.jaad.2017.08.039
   PubMed Web of Science ®Google Scholar
• Luke JJ, Flaherty KT, Ribas A, et al. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol. 2017;14(8):463–482. doi:10.1038/nrclinonc.2017.43
   PubMed Web of Science ®Google Scholar
• Da silveira nogueira lima JP, Georgieva M, Haaland B, et al. A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma. Cancer Med. 2017;6(6):1143–1153. doi:10.1002/cam4.1001
   PubMed Web of Science ®Google Scholar
• Currie E, Schulze A, Zechner R, et al. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153–161. doi:10.1016/j.cmet.2013.05.017
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2016;73(2):377–392. doi:10.1007/s00018-015-2070-4
   PubMed Web of Science ®Google Scholar
• Jin Z, Chai YD, Hu S. Fatty Acid Metabolism and Cancer. Adv Exp Med Biol. 2021;1280:231–241.
   PubMed Web of Science ®Google Scholar
• Ma B, Zhang A, Zhao Q, et al. Genome-wide identification and analysis of long non-coding RNAs involved in fatty acid biosynthesis in young soybean pods. Sci Rep. 2021;11(1):7603. doi:10.1038/s41598-021-87048-7
   PubMed Web of Science ®Google Scholar
• Wu H, Liu B, Chen Z, et al. MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer. Cell Death Dis. 2020;11(4):233. doi:10.1038/s41419-020-2426-z
   PubMed Web of Science ®Google Scholar
• Zhu J, Fu H, Wu Y, et al. Function of lncRNAs and approaches to lncRNA-protein interactions. Sci China Life Sci. 2013;56(10):876–885. doi:10.1007/s11427-013-4553-6
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437. doi:10.1038/nm.3394
   PubMed Web of Science ®Google Scholar
• Lu J, Wang X, Sun K, et al. Chrom-Lasso: a lasso regression-based model to detect functional interactions using Hi-C data. Brief Bioinform. 2021;22(6). doi:10.1093/bib/bbab181
   Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955–61. doi:10.1093/nar/gks1111
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Huang B, Han W, Sheng Z-F, et al. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients. Cancer Cell Int. 2020;20(1):195. doi:10.1186/s12935-020-01271-2
   PubMed Web of Science ®Google Scholar
• Pelster MS, Amaria RN. Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trials. Ther Adv Med Oncol. 2019;11:1758835919830826. doi:10.1177/1758835919830826
   Web of Science ®Google Scholar
• Rastrelli M, et al. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. Vivo. 2014;28(6):1005–1011.
   PubMed Web of Science ®Google Scholar
• Namikawa K, Yamazaki N. Targeted Therapy and Immunotherapy for Melanoma in Japan. Curr Treat Options Oncol. 2019;20(1):7. doi:10.1007/s11864-019-0607-8
   PubMed Web of Science ®Google Scholar
• Saab J, Santos-Zabala ML, Loda M, et al. Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi. Am J Dermatopathol. 2018;40(4):259–264. doi:10.1097/DAD.0000000000000939
   PubMed Web of Science ®Google Scholar
• Eykelenboom JE, Briggs GJ, Bradshaw NJ, et al. A t(1;11) translocation linked to schizophrenia and affective disorders gives rise to aberrant chimeric DISC1 transcripts that encode structurally altered, deleterious mitochondrial proteins. Hum Mol Genet. 2012;21(15):3374–3386. doi:10.1093/hmg/dds169
   PubMed Web of Science ®Google Scholar
• Brandon NJ, Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci. 2011;12(12):707–722. doi:10.1038/nrn3120
   PubMed Web of Science ®Google Scholar
• Norkett R, Modi S, Birsa N, et al. DISC1-dependent Regulation of Mitochondrial Dynamics Controls the Morphogenesis of Complex Neuronal Dendrites. J Biol Chem. 2016;291(2):613–629. doi:10.1074/jbc.M115.699447
   PubMed Web of Science ®Google Scholar
• Ryan NM, Lihm J, Kramer M, et al. DNA sequence-level analyses reveal potential phenotypic modifiers in a large family with psychiatric disorders. Mol Psychiatry. 2018;23(12):2254–2265. doi:10.1038/s41380-018-0087-4
   PubMed Web of Science ®Google Scholar
• Ji B, Higa KK, Kim M, et al. Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders. Hum Mol Genet. 2014;23(21):5683–5705. doi:10.1093/hmg/ddu285
   PubMed Web of Science ®Google Scholar
• Li X, Jin F, Li Y. A novel autophagy-related lncRNA prognostic risk model for breast cancer. J Cell Mol Med. 2021;25(1):4–14. doi:10.1111/jcmm.15980
   PubMed Web of Science ®Google Scholar
• Wu Q, Li Q, Zhu W, et al. Identification of autophagy-related long non-coding RNA prognostic signature for breast cancer. J Cell Mol Med. 2021;25(8):4088–4098. doi:10.1111/jcmm.16378
   PubMed Web of Science ®Google Scholar
• Ma W, Zhao F, Yu X, et al. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature. J Transl Med. 2020;18(1):442. doi:10.1186/s12967-020-02522-6
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu Y, Zhang J, et al. An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer. J Oncol. 2021;2021:9972454. doi:10.1155/2021/9972454
   PubMed Web of Science ®Google Scholar
• Choi JH, Kwon SM, Moon SU, et al. TPRG1-AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR-4691-5p and miR-3659. Liver Int. 2021;41(11):2788–2800. doi:10.1111/liv.15026
   PubMed Web of Science ®Google Scholar
• Ma J, Qi G, Li L. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis. Cell Mol Biol Lett. 2020;25(1):34. doi:10.1186/s11658-020-00227-8
   PubMed Web of Science ®Google Scholar
• Yao C, Cheng X, Guo X, et al. NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis. Cancer Cell Int. 2020;20(1):463. doi:10.1186/s12935-020-01505-3
   PubMed Web of Science ®Google Scholar
• Liu Y, Guo R, Qiao Y, et al. LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis. Cancer Cell Int. 2020;20(1):190. doi:10.1186/s12935-020-01278-9
   PubMed Web of Science ®Google Scholar
• Zheng D, Chen D, Lin F, et al. LncRNA NNT-AS1 promotes glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis. Cell Cycle. 2020;19(13):1621–1631. doi:10.1080/15384101.2020.1762037
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu G. NNT-AS1 enhances bladder cancer cell growth by targeting miR-1301-3p/PODXL axis and activating Wnt pathway. Neurourol Urodyn. 2020;39(2):547–557. doi:10.1002/nau.24238
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhu Z, Lan Y, et al. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients. Front Immunol. 2021;12:659444. doi:10.3389/fimmu.2021.659444
   PubMed Web of Science ®Google Scholar
• Spranger S, Spaapen RM, Zha Y, et al. Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells. Sci Transl Med. 2013;5(200):200ra116. doi:10.1126/scitranslmed.3006504
   PubMed Web of Science ®Google Scholar
• Yan K, Lu Y, Yan Z, et al. 9-Gene Signature Correlated With CD8(+) T Cell Infiltration Activated by IFN-γ: a Biomarker of Immune Checkpoint Therapy Response in Melanoma. Front Immunol. 2021;12:622563. doi:10.3389/fimmu.2021.622563
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kurupati R, Liu L, et al. Enhancing CD8(+) T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy. Cancer Cell. 2017;32(3):377–391.e9. doi:10.1016/j.ccell.2017.08.004
   PubMed Web of Science ®Google Scholar
• Bardi GT, Smith MA, Hood JL. Melanoma exosomes promote mixed M1 and M2 macrophage polarization. Cytokine. 2018;105:63–72. doi:10.1016/j.cyto.2018.02.002
   PubMed Web of Science ®Google Scholar
• Cao M, Yan H, Han X, et al. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. J Immunother Cancer. 2019;7(1):326. doi:10.1186/s40425-019-0817-4
   PubMed Web of Science ®Google Scholar
• Falleni M, Savi F, Tosi D, et al. M1 and M2 macrophages’ clinicopathological significance in cutaneous melanoma. Melanoma Res. 2017;27(3):200–210. doi:10.1097/CMR.0000000000000352
   PubMed Web of Science ®Google Scholar
• Jarosz-Biej M, Kamińska N, Matuszczak S, et al. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma. PLoS One. 2018;13(1):e0191012. doi:10.1371/journal.pone.0191012
   PubMed Web of Science ®Google Scholar
• Park SM, Do-Thi VA, Lee J-O, et al. Interleukin-9 Inhibits Lung Metastasis of Melanoma through Stimulating Anti-Tumor M1 Macrophages. Mol Cells. 2020;43(5):479–490. doi:10.14348/molcells.2020.0047
   PubMed Web of Science ®Google Scholar